Fundraising FoxColibri Heart Valve
Broomfield, US · Founded 2010 · Delaware LLC
Find your way into Colibri Heart Valve
Sign up to see every warm intro you have to Colibri Heart Valve
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Colibri Heart Valve team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Colibri Heart Valve is a medical device company developing the Colibri TAVI System, a ready-for-use transfemoral heart valve delivered directly from its package using a low-profile (9Fr) balloon delivery system. The company's products are in clinical development and not yet offered for sale.
Founders & leadership
Colibri Heart Valve was founded in 2010 by R. David Fish.
RD
R. David FishFounder
WJ
William JacksonVice President of Regulatory Compliance & Clinical
JH
Joseph H. HornPresident and CEO
ES
Eric SchaubleVice President, Corporate Development
JB
Joseph B. HornExecutive
DP
David PaniaguaNamed on SEC filing
Board
DR
David R. FishBoard director
JG
James GleasonBoard director
TP
Thomas P. ReaganCorporate and Financial Advisor
Reported raises · per SEC filings
Form D private placements$6.9M disclosed across 3 rounds · 2011–2015
▶$1.3MraisedMar 2016 · 6 investors · Other TechnologyRule 506(b)
▶$1.3MraisedMar 2016 · 6 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- David R. FishDirector
- William JacksonExecutive Officer
- David PaniaguaDirector
- Joseph H. HornExecutive Officer, Director
- Eric SchaubleExecutive Officer
- James GleasonDirector
- Thomas P. ReaganDirector
- Offering amount
- $25M
- Amount sold
- $1.3M
- Minimum investment
- $100K
- First sale
- Sep 2015
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$750KraisedMar 2014 · 2 investors · Other TechnologyRule 506(b)
▶$750KraisedMar 2014 · 2 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- James GleasonDirector
- Thomas P. ReaganDirector
- David PaniaguaDirector
- R. David FishDirector
- Joseph B. HornExecutive Officer, Director
- Eric SchaubleExecutive Officer
- Offering amount
- $3M
- Amount sold
- $750K
- Minimum investment
- $50K
- First sale
- Mar 2014
- Incorporated
- Limited Liability Company, Delaware, 2010
- Federal exemptions
- 06b
▶$4.9MraisedJan 2012 · 20 investors · Other TechnologyRule 506(b)
▶$4.9MraisedJan 2012 · 20 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Eric SchaubleExecutive Officer
- Joseph B. HornExecutive Officer, Director, Promoter
- David PaniaguaExecutive Officer, Director, Promoter
- R. David FishExecutive Officer, Director, Promoter
- Offering amount
- $5M
- Amount sold
- $4.9M
- Minimum investment
- $50K
- Proceeds to insiders
- $1M
- Placement agents
- Janco Partners, Inc.
- First sale
- Sep 2011
- Incorporated
- Limited Liability Company, Delaware, 2010
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
Boston ScientificBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
Edwards LifesciencesEdwards Lifesciences develops innovative medical technologies for treating cardiovascular disease, focusing on structural heart interventions. The company serves patients and healthcare providers globally through partnerships with clinicians and healthcare stakeholders.
Rf SurgicalMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Companies working in the same space as Colibri Heart Valve.
In the news
Frequently asked questions
- What does Colibri Heart Valve do?
- Colibri Heart Valve is a medical device company developing the Colibri TAVI System, a ready-for-use transfemoral heart valve delivered directly from its package using a low-profile (9Fr) balloon delivery system. The company's products are in clinical development and not yet offered for sale.
- Who founded Colibri Heart Valve?
- Colibri Heart Valve was founded by R. David Fish in 2010.
- How much funding has Colibri Heart Valve raised?
- Colibri Heart Valve has disclosed $6.9M raised across 3 rounds.
- Where is Colibri Heart Valve headquartered?
- Colibri Heart Valve is headquartered in Broomfield, US.